Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell Carcinoma
Clinical trial NCT05188118 · COMPLETED
Trial details
- NCT number
- NCT05188118
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2026-06-05
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.